Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

ETP Nanomedicine and NANOMED2020: Towards a New Nanomedicine Horizon
SELECTBIO

The European Technology Platform on Nanomedicine (ETPN) is an initiative set-up in 2005 to define the strategic research priorities to be funded in the field, led by industry and officially recognized by the European Commission (EC) as part of the external advice and societal engagement needed to implement the coming Framework Program called Horizon 2020. The ETPN is addressing the application of nanotechnology to achieve breakthroughs in healthcare and conducted in the last year under the NANOMED2020 EU project several analyses, studies and interviews to map all actors in Nanomedicine in Europe and to define the needs for the successful translation of outstanding research into innovative products. 

Request more information
Company product page


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Boys More Likely to Have Antipsychotics Prescribed, Regardless of Age
NIH-funded study is the first look at antipsychotic prescriptions patterns in the U.S.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
New Medication for Alcohol Use Disorder
NIH begins clinical trial investigating a potential treatment for alcohol use disorder.
Behavior Matters: Redesigning the Clinical Trial
A recent meta-analysis of six such clinical trials shows that behavior can have a serious impact on the effectiveness of a treatment and that the currently used DBRCT procedures may not be able to assess the effects of behavior on the treatment.
New Commercial Method for Producing Medical Isotope
The effort to secure a stable, domestic source of a critical medical isotope reached an important milestone this month as scientists demonstrated the production, separation and purification of molybdenum-99 (Mo-99.
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
Precision medicine trial will open to patient enrollment in July.
Linking Targeted Cancer Drugs to Gene Abnormalities
Investigators at the NIH have announced a series of clinical trials that will study drugs or drug combinations that target specific genetic mutations.
IAOCR Welcomes Important Initial Step for Regulating European Clinical Trials
New regulation to ensure a more streamlined risk-based approach to the conduct of trials with more public openness about each trial and the results they produce.
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Amgen Terminates Co-Development of Brodalumab with AstraZeneca
This move follows the release of clinical trial data which suggests the experimental drug has severe side effects.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters